Dr. Feng Wang 王枫
Chief Physician
Department of Thoracic Surgical Oncology, Fujian Cancer Hospital, Fuzhou
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Surgical and minimally invasive laparoscopic treatment of esophageal, lung, esophagogastric junction, mediastinal, and chest wall tumors.
Dr. Wang is Chief Physician and Administrative Deputy Director of Ward 1, Department of Thoracic Oncology Surgery. With 20 years of experience, Dr. Wang specializes in surgical and minimally invasive procedures for thoracic tumors. Training includes fellowships at the Cancer Hospital of the Chinese Academy of Medical Sciences and Shanghai Chest Hospital.
Professional roles
- Member, Esophageal Cancer Professional Committee, China Anti-Cancer Association
- Standing Committee Member, Esophageal Cancer Professional Committee, Fujian Anti-Cancer Association
- Chair, Youth Committee on Esophageal Cancer, Fujian Anti-Cancer Association
- Vice Chair, Youth Committee, Oncology Society, Fujian Medical Association
Name order: in Chinese the family name comes first (Wang Feng). Papers usually list the name as Feng Wang or Wang F.
Selected publications
75 papers on PubMed matched by name and affiliation; 42 as first or senior author since 2016. Most recent first- or senior-author papers:
- Ann Surg Oncol, 2026 (senior author): ASO Visual Abstract: Nodal Zone Count Versus ypN Stage for Predicting First Distant Metastasis After Neoadjuvant Therapy and Esophagectomy in Esophageal Squamous Cell Carcinoma. PubMed 42995353
- Ann Surg Oncol, 2026 (senior author): ASO Author Reflections: Beyond Node Counts: The Geography of Residual Nodal Disease After Neoadjuvant Therapy. PubMed 42862520
- Surg Endosc, 2026 (senior author): Technical key points and short-term outcomes of fascia-guided radical esophagectomy: a single-center retrospective database analysis. PubMed 42816640
- Ann Thorac Surg, 2026 (senior author): Metastatic Lymph Node Station Count and Risk of First Distant Metastasis After Neoadjuvant Therapy in Esophageal Squamous Cell Carcinoma. PubMed 42744128
- Ann Surg Oncol, 2026 (senior author): Nodal Zone Count Versus ypN Stage for Predicting First Distant Metastasis After Neoadjuvant Therapy and Esophagectomy in Esophageal Squamous Cell Carcinoma. PubMed 42706470
- Ann Surg Oncol, 2026 (senior author): ASO Author Reflections: T12-Sarcopenia After Neoadjuvant Chemoimmunotherapy Predicts Poor Prognosis in Esophageal Squamous Cell Carcinoma. PubMed 42289627
- Ann Surg Oncol, 2026 (senior author): Prognostic Significance of the T12-SMI Before and After Neoadjuvant Chemoimmunotherapy for Esophageal Squamous Cell Carcinoma. PubMed 42251209
- Cancer Nurs, 2026 (senior author): Association of Physical Activity, Sleep Duration, and Trouble Sleeping With Survival Among US Cancer Survivors: A Population-Based Cohort Study. PubMed 42276573
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital. This name is shared by other researchers, so we checked that the papers match this doctor's specialty; this check is automatic.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion